Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -251.23M | -237.09M | -210.57M | -193.45M | -166.13M |
| Total Depreciation and Amortization | 6.32M | 5.81M | 5.89M | 5.81M | 5.93M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.44M | 17.55M | 15.45M | 15.32M | 17.04M |
| Change in Net Operating Assets | 16.27M | 3.45M | 7.46M | 7.69M | -3.12M |
| Cash from Operations | -208.21M | -210.28M | -181.76M | -164.63M | -146.28M |
| Capital Expenditure | -7.07M | -8.83M | -9.59M | -6.91M | -4.75M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 230.35M | 170.97M | 203.62M | 14.14M | -26.99M |
| Cash from Investing | 223.28M | 162.15M | 194.03M | 7.23M | -31.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.03M | 783.00K | 1.03M | 1.03M | 118.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.37M | 55.24M | -- | -- | -- |
| Cash from Financing | 54.40M | 56.03M | 1.03M | 1.03M | 118.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.47M | 7.89M | 13.29M | -156.38M | -59.79M |